| Dual-specificity MAP kinase phosphatases as targets of cancer treatment C Nunes-Xavier, C Roma-Mateo, P Rios, C Tarrega, R Cejudo-Marin, ... Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 11 (1), 109-132, 2011 | 146 | 2011 |
| B7-H3 in cancer–beyond immune regulation K Flem-Karlsen, Ø Fodstad, M Tan, CE Nunes-Xavier Trends in cancer 4 (6), 401-404, 2018 | 143 | 2018 |
| Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c MK Nygren, C Tekle, VA Ingebrigtsen, R Mäkelä, M Krohn, MR Aure, ... British journal of cancer 110 (8), 2072-2080, 2014 | 136 | 2014 |
| Dual-specificity phosphatases as molecular targets for inhibition in human disease P Rios, CE Nunes-Xavier, L Tabernero, M Köhn, R Pulido Antioxidants & redox signaling 20 (14), 2251-2273, 2014 | 101 | 2014 |
| Protein tyrosine phosphatases as novel targets in breast cancer therapy CE Nunes-Xavier, J Martín-Pérez, A Elson, R Pulido Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (2), 211-226, 2013 | 88 | 2013 |
| Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors CE Nunes-Xavier, KF Karlsen, C Tekle, C Pedersen, T Øyjord, V Hongisto, ... Oncotarget 7 (6), 6891, 2016 | 85 | 2016 |
| A critical insight into the clinical translation of PD-1/PD-L1 blockade therapy in clear cell renal cell carcinoma CE Nunes-Xavier, JC Angulo, R Pulido, JI López Current urology reports 20, 1-10, 2019 | 78 | 2019 |
| B7-H3 immune checkpoint protein in human cancer K Flem-Karlsen, Ø Fodstad, CE Nunes-Xavier Current medicinal chemistry 27 (24), 4062-4086, 2020 | 73 | 2020 |
| Differential up-regulation of MAP kinase phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun converge in the control of the growth arrest versus proliferation response of MCF-7 … CE Nunes-Xavier, C Tarrega, R Cejudo-Marin, J Frijhoff, Å Sandin, ... Journal of Biological Chemistry 285 (34), 26417-26430, 2010 | 72 | 2010 |
| Immunoregulatory protein B7‐H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells K Flem‐Karlsen, C Tekle, Y Andersson, K Flatmark, Ø Fodstad, ... Pigment cell & melanoma research 30 (5), 467-476, 2017 | 70 | 2017 |
| The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder J Calvete, G Larrinaga, P Errarte, AM Martin, A Dotor, C Esquinas, ... Human pathology 91, 61-68, 2019 | 65 | 2019 |
| The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases P Errarte, R Guarch, R Pulido, L Blanco, CE Nunes-Xavier, M Beitia, J Gil, ... PLoS One 11 (12), e0169105, 2016 | 59 | 2016 |
| p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance K Flem-Karlsen, C Tekle, T Øyjord, VA Flørenes, GM Mælandsmo, ... Scientific reports 9 (1), 5839, 2019 | 40 | 2019 |
| The extended family of protein tyrosine phosphatases A Alonso, CE Nunes-Xavier, Y Bayón, R Pulido Protein Tyrosine Phosphatases: Methods and Protocols, 1-23, 2016 | 38 | 2016 |
| The role of protein tyrosine phosphatases in prostate cancer biology CE Nunes-Xavier, J Mingo, JI Lopez, R Pulido Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1866 (1), 102-113, 2019 | 27 | 2019 |
| Epidermal Growth Factor Receptor (EGFR)-mediated Positive Feedback of Protein-Tyrosine Phosphatase ϵ (PTPϵ) on ERK1/2 and AKT Protein Pathways Is Required for Survival of Human … CE Nunes-Xavier, A Elson, R Pulido Journal of Biological Chemistry 287 (5), 3433-3444, 2012 | 27 | 2012 |
| Hopes on immunotherapy targeting B7-H3 in neuroblastoma R Pulido, CE Nunes-Xavier Translational Oncology 27, 101580, 2023 | 22 | 2023 |
| Caspase-3 cleavage of DUSP6/MKP3 at the interdomain region generates active MKP3 fragments that regulate ERK1/2 subcellular localization and function R Cejudo-Marín, C Tárrega, CE Nunes-Xavier, R Pulido Journal of molecular biology 420 (1-2), 128-138, 2012 | 22 | 2012 |
| Immune checkpoint B7‐H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer CE Nunes‐Xavier, W Kildal, A Kleppe, HE Danielsen, H Wæhre, ... The Prostate 81 (12), 838-848, 2021 | 18 | 2021 |
| Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology J Mingo, S Luna, A Gaafar, CE Nunes-Xavier, L Torices, L Mosteiro, ... NPJ precision oncology 3 (1), 11, 2019 | 18 | 2019 |
José I. López, MD, PhDBiobizkaia Health Research Instituteایمیل تأیید شده در biocrucesbizkaia.org
